Guest Post
The cost of sequencing the human genome continues to fall, reaching a low of $1,000 this year due to a new microchip and machine designed by genetics company Life Technologies Corp. And unleashed by those lower costs, a small cadre …
TODAY’S HEADLINES:
Oxford NanoLabs takes in £10M for sequencing tech (PDF release)
Alure Medical raises $4.5M for plastic-surgery implants (release)
Bone-disease biotech Therosteon spins out of research institute, raises funds (PDF release)
Genome-analysis toolmaker BioTrove files for $75M IPO (Edgar)
…
TODAY’S HEADLINES:
Compact ultrasound maker Zonare Medical raises $30M (VentureWire)
TherOx raises $30M for hypersaturated-oxygen devices (peHUB)
Accumetrics, antiplatelet-drug diagnostic maker, raises $29M (release)
Population Genetics takes in £3.8M for massively parallel genome studies (GenomeWeb)
“Brain fitness” trainer Dakim raises
…
TODAY’S HEADLINES:
Metabolic-disease biotech NGM Biopharma raises $25M (peHUB)
Heart, HIV drug maker Numerate acquires assets of Pharmix (release)
Next-gen sequencer VisiGen promises $1,000 genome by late 2009 (Genome Technology)
CalciMedica raises $5.5M for autoimmune drugs (VentureWire)
Cancer-drug e-marketplace OneOncology
…
More than a half-dozen startups and established companies are in hot pursuit of the “$1,000 genome,” a Holy Grail for those who believe fast, cheap genome sequencing will revolutionize medicine. The latest is Pacific Biosciences, a formerly secretive Menlo Park, …
Competition to analyze human genomes faster and cheaper — a subject I’ve discussed at length here and here — keeps heating up. The latest shot came yesterday, when Menlo Park, Calif.-based Pacific Biosciences granted the NYT an exclusive look at …
TODAY’S HEADLINES:
Joint-implant maker Ascension Orthopedics raises $21M (release)
High-speed sequencer Genome Corp. draws another $250K (GenomeWeb News)
Bausch & Lomb acquires implantable lens maker Eyeonics (release)
Bederra buys up Houston’s Diagnos and its PET-scan diagnostics (release)
High-speed sequencer Genome …
The cost of sequencing human genomes is dropping steadily, from several hundred million dollars a decade ago to $100,000 or so today, thanks to a bevy of entrepreneurial companies that have attacked the problem of making the process faster and …
Things are starting to get crowded in the race to sequence entire human genomes quickly and relatively cheaply — usually meaning somewhere in the territory of $1,000 per genome, compared to the $100,000+ it costs with current technology. At least …
Featured companies: CG Therapeutics, Complete Genomics, ConforMIS, Flexible Medical Systems, LeMaitre Vascular, MAP Pharmaceuticals, ParaPro, Vascular Architects, Zars Pharma
(UPDATED on 10/1/07: See below.)
[NOTE: Posting has been slow recently for personal reasons. I'll be doing my …
(UPDATED at 5:55pm PT: See below.)
Featured companies: Sierra Surgical Technologies, HerbalScience Nutraceuticals, Topigen Pharmaceuticals, EKR Therapeutics, Molecular Partners, Celsense, Glucose Sensing Technologies, Falcon Genomics, Waters, Calorimetry Sciences, Parion Sciences, Gilead Sciences, Isto Technologies, Fluidnet, NABsys
Sierra Surgical raises …
Helicos BioSciences, a Cambridge, Mass., maker of high-speed genome-sequencing equipment, raised $48.6 million in an IPO, well under the $81 million it had hoped to raise. My earlier item on the Helicos IPO is here.
Helicos is the latest biotechnology …
